Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 4895050, 7 pages
http://dx.doi.org/10.1155/2016/4895050
Review Article

A Tale of Two Joints: The Role of Matrix Metalloproteases in Cartilage Biology

Department of Physiology and Developmental Biology, Brigham Young University (BYU), LSB 4005, Provo, UT 84602, USA

Received 26 March 2016; Accepted 12 June 2016

Academic Editor: Fatma M. El-Demerdash

Copyright © 2016 Brandon J. Rose and David L. Kooyman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Hattori, S. Mochizuki, K. Kishi et al., “MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing,” The American Journal of Pathology, vol. 175, no. 2, pp. 533–546, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Shi, M.-Y. Son, S. Yamada et al., “Membrane-type MMPs enable extracellular matrix permissiveness and mesenchymal cell proliferation during embryogenesis,” Developmental Biology, vol. 313, no. 1, pp. 196–209, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Chubinskaya, K. E. Kuettner, and A. A. Cole, “Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints,” Laboratory Investigation, vol. 79, no. 12, pp. 1669–1677, 1999. View at Google Scholar · View at Scopus
  4. S. Gack, R. Vallon, J. Schmidt et al., “Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes,” Cell Growth & Differentiation, vol. 6, no. 6, pp. 759–767, 1995. View at Google Scholar · View at Scopus
  5. H. Wu, J. Du, and Q. Zheng, “Expression of MMP-1 in cartilage and synovium of experimentally induced rabbit ACLT traumatic osteoarthritis: immunohistochemical study,” Rheumatology International, vol. 29, no. 1, pp. 31–36, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Salo, M. Mäkelä, M. Kylmäniemi, H. Autio-Harmainen, and H. Larjava, “Expression of matrix metalloproteinase-2 and-9 during early human wound healing,” Laboratory Investigation; A Journal of Technical Methods and Pathology, vol. 70, no. 2, pp. 176–182, 1994. View at Google Scholar
  7. S. Duerr, S. Stremme, S. Soeder, B. Bau, and T. Aigner, “MMP-2/gelatinase A is a gene product of human adult articular chondrocytes and is increased in osteoarthritic cartilage,” Clinical and Experimental Rheumatology, vol. 22, no. 5, pp. 603–608, 2004. View at Google Scholar · View at Scopus
  8. T. Eguchi, S. Kubota, K. Kawata et al., “Novel transcription factor-like function of human matrix metalloproteinase 3 regulating the CTGF/CCN2 gene,” Molecular and Cellular Biology, vol. 28, no. 7, pp. 2391–2413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. L. Warner, N. Bhagavathula, K. C. Nerusu et al., “Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro,” Experimental and Molecular Pathology, vol. 76, no. 3, pp. 189–195, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Okada, M. Shinmei, O. Tanaka et al., “Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium,” Laboratory Investigation, vol. 66, no. 6, pp. 680–690, 1992. View at Google Scholar · View at Scopus
  11. E. Kubota, H. Imamura, T. Kubota, T. Shibata, and K.-I. Murakami, “Interleukin 1β and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint,” Journal of Oral and Maxillofacial Surgery, vol. 55, no. 1, pp. 20–28, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Sulkala, T. Tervahartiala, T. Sorsa, M. Larmas, T. Salo, and L. Tjäderhane, “Matrix metalloproteinase-8 (MMP-8) is the major collagenase in human dentin,” Archives of Oral Biology, vol. 52, no. 2, pp. 121–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Van Lint and C. Libert, “Matrix metalloproteinase-8: cleavage can be decisive,” Cytokine & Growth Factor Reviews, vol. 17, no. 4, pp. 217–223, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Pirilä, J. T. Korpi, T. Korkiamäki et al., “Collagenase-2 (MMP-8) and matrilysin-2 (MMP-26) expression in human wounds of different etiologies,” Wound Repair and Regeneration, vol. 15, no. 1, pp. 47–57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. Cox, A. E. Starr, R. Kappelhoff, R. Yan, C. R. Roberts, and C. M. Overall, “Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression,” Arthritis and Rheumatism, vol. 62, no. 12, pp. 3645–3655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. H. Vu, J. M. Shipley, G. Bergers et al., “MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes,” Cell, vol. 93, no. 3, pp. 411–422, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. C. B. Little, A. Barai, D. Burkhardt et al., “Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development,” Arthritis and Rheumatism, vol. 60, no. 12, pp. 3723–3733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Söder, H. I. Roach, S. Oehler, B. Bau, J. Haag, and T. Aigner, “MMP-9/gelatinase B is a gene product of human adult articular chondrocytes and increased in osteoarthritic cartilage,” Clinical and Experimental Rheumatology, vol. 24, no. 3, pp. 302–304, 2006. View at Google Scholar · View at Scopus
  19. R. Dreier, S. Grässel, S. Fuchs, J. Schaumburger, and P. Bruckner, “Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade,” Experimental Cell Research, vol. 297, no. 2, pp. 303–312, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Shiomi, V. Lemaître, J. D'Armiento, and Y. Okada, “Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases,” Pathology International, vol. 60, no. 7, pp. 477–496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. J. A. C. Hawinkels, P. Kuiper, E. Wiercinska et al., “Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis,” Cancer Research, vol. 70, no. 10, pp. 4141–4150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Yang, M. Attur, T. Kirsch et al., “Membrane-type 1 matrix metalloproteinase controls osteo-and chondrogenesis by a proteolysis-independent mechanism mediated by its cytoplasmic tail,” Osteoarthritis and Cartilage, vol. 23, article A64, 2015. View at Publisher · View at Google Scholar
  23. J. Esparza, C. Vilardell, J. Calvo et al., “Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways,” Blood, vol. 94, no. 8, pp. 2754–2766, 1999. View at Google Scholar · View at Scopus
  24. V. Knäuper, H. Will, C. López-Otin et al., “Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme,” The Journal of Biological Chemistry, vol. 271, no. 29, pp. 17124–17131, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Polur, P. L. Lee, J. M. Servais, L. Xu, and Y. Li, “Role of HTRA1, a serine protease, in the progression of articular cartilage degeneration,” Histology and Histopathology, vol. 25, no. 5, pp. 599–608, 2010. View at Google Scholar · View at Scopus
  26. H. Xu, N. Raynal, S. Stathopoulos, J. Myllyharju, R. W. Farndale, and B. Leitinger, “Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1,” Matrix Biology, vol. 30, no. 1, pp. 16–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Su, J. Yu, T. Ren et al., “Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis,” Molecular and Cellular Biochemistry, vol. 330, no. 1-2, pp. 141–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Xu, H. Peng, D. Wu et al., “Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice,” The Journal of Biological Chemistry, vol. 280, no. 1, pp. 548–555, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Xu, J. Servais, I. Polur et al., “Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice,” Arthritis and Rheumatism, vol. 62, no. 9, pp. 2736–2744, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. R. R. Yammani and R. F. Loeser, “Stress-inducible nuclear protein 1 regulates matrix metalloproteinase 13 expression in human articular chondrocytes,” Arthritis & Rheumatology, vol. 66, no. 5, pp. 1266–1271, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Xu, Y. Huang, D. Cai, J. Liu, and X. Cao, “Analysis of differences in the molecular mechanism of rheumatoid arthritis and osteoarthritis based on integration of gene expression profiles,” Immunology Letters, vol. 168, no. 2, pp. 246–253, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Araki, T. T. Wada, Y. Aizaki et al., “Histone methylation and STAT-3 differentially regulate interleukin-6- induced matrix metalloproteinase gene activation in rheumatoid arthritis synovial fibroblasts,” Arthritis & Rheumatology, vol. 68, no. 5, pp. 1111–1123, 2016. View at Google Scholar
  33. S. Sugita, Y. Hosaka, K. Okada et al., “Transcription factor Hes1 modulates osteoarthritis development in cooperation with calcium/calmodulin-dependent protein kinase 2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 10, pp. 3080–3085, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. B.-G. Ju, D. Solum, E. J. Song et al., “Activating the PARP-1 sensor component of the groucho/ TLE1 corepressor complex mediates a CaMKinase IIδ-dependent neurogenic gene activation pathway,” Cell, vol. 119, no. 6, pp. 815–829, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Kageyama, T. Ohtsuka, and T. Kobayashi, “The Hes gene family: repressors and oscillators that orchestrate embryogenesis,” Development, vol. 134, no. 7, pp. 1243–1251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. E. J. Ezratty, N. Stokes, S. Chai, A. S. Shah, S. E. Williams, and E. Fuchs, “A role for the primary cilium in notch signaling and epidermal differentiation during skin development,” Cell, vol. 145, no. 7, pp. 1129–1141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. H. Kong, L. Yang, E. Dessaud et al., “Notch activity modulates the responsiveness of neural progenitors to sonic hedgehog signaling,” Developmental Cell, vol. 33, no. 4, pp. 373–387, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Niebler, T. Schubert, E. B. Hunziker, and A. K. Bosserhoff, “Activating enhancer binding protein 2 epsilon (AP-2ε)-deficient mice exhibit increased matrix metalloproteinase 13 expression and progressive osteoarthritis development,” Arthritis Research and Therapy, vol. 17, article 119, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. K. E. Barbour, C. G. Helmick, K. A. Theis et al., “Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2010–2012,” Morbidity and Mortality Weekly Report, vol. 62, no. 44, pp. 869–873, 2013. View at Google Scholar · View at Scopus
  40. M. Grotle, K. B. Hagen, B. Natvig, F. A. Dahl, and T. K. Kvien, “Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up,” BMC Musculoskeletal Disorders, vol. 9, article 132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Ribeiro, P. López de Figueroa, F. Blanco, A. Mendes, and B. Caramés, “Insulin decreases autophagy and leads to cartilage degradation,” Osteoarthritis and Cartilage, vol. 24, no. 4, pp. 731–739, 2016. View at Publisher · View at Google Scholar
  42. D. Hamada, R. Maynard, E. Schott et al., “Insulin suppresses TNF-dependent early osteoarthritic changes associated with obesity and type 2 diabetes,” Arthritis & Rheumatology, vol. 68, no. 6, pp. 1392–1402, 2016. View at Publisher · View at Google Scholar
  43. N. Yoshimura, S. Muraki, H. Oka et al., “Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: A 3-year Follow-Up of the ROAD Study,” Osteoarthritis and Cartilage, vol. 20, no. 11, pp. 1217–1226, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. I.-E. Triantaphyllidou, E. Kalyvioti, E. Karavia, I. Lilis, K. E. Kypreos, and D. J. Papachristou, “Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet,” Osteoarthritis and Cartilage, vol. 21, no. 2, pp. 322–330, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Iliopoulos, K. N. Malizos, and A. Tsezou, “Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention,” Annals of the Rheumatic Diseases, vol. 66, no. 12, pp. 1616–1621, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Pallu, P.-J. Francin, C. Guillaume et al., “Obesity affects the chondrocyte responsiveness to leptin in patients with osteoarthritis,” Arthritis Research and Therapy, vol. 12, no. 3, article R112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Koskinen, K. Vuolteenaho, R. Nieminen, T. Moilanen, and E. Moilanen, “Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients,” Clinical and Experimental Rheumatology, vol. 29, no. 1, pp. 57–64, 2011. View at Google Scholar · View at Scopus
  48. P.-J. Francin, A. Abot, C. Guillaume et al., “Association between adiponectin and cartilage degradation in human osteoarthritis,” Osteoarthritis and Cartilage, vol. 22, no. 3, pp. 519–526, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. E. H. Kang, Y. J. Lee, T. K. Kim et al., “Adiponectin is a potential catabolic mediator in osteoarthritis cartilage,” Arthritis Research and Therapy, vol. 12, no. 6, article R231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Soro-Paavonen, A. M. D. Watson, J. Li et al., “Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes,” Diabetes, vol. 57, no. 9, pp. 2461–2469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. D. J. Larkin, J. Z. Kartchner, A. S. Doxey et al., “Inflammatory markers associated with osteoarthritis after destabilization surgery in young mice with and without Receptor for Advanced Glycation End-products (RAGE),” Frontiers in Physiology, vol. 4, article 121, Article ID Artisle 121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. J. A. Roman-Blas and S. A. Jimenez, “NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis,” Osteoarthritis and Cartilage, vol. 14, no. 9, pp. 839–848, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. A. R. Klatt, G. Klinger, O. Neumüller et al., “TAK1 downregulation reduces IL-1β induced expression of MMP13, MMP1 and TNF-alpha,” Biomedicine and Pharmacotherapy, vol. 60, no. 2, pp. 55–61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. Z. Fan, H. Yang, B. Bau, S. Söder, and T. Aigner, “Role of mitogen-activated protein kinases and NFκB on IL-1β-induced effects on collagen type II, MMP-1 and 13 mRNA expression in normal articular human chondrocytes,” Rheumatology International, vol. 26, no. 10, pp. 900–903, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. Z. Tang, L. Yang, Y. Wang et al., “Contributions of different intraarticular tissues to the acute phase elevation of synovial fluid MMP-2 following rat ACL rupture,” Journal of Orthopaedic Research, vol. 27, no. 2, pp. 243–248, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Liacini, J. Sylvester, W. Q. Li et al., “Induction of matrix metalloproteinase-13 gene expression by TNF-α is mediated by MAP kinases, AP-1, and NF-κB transcription factors in articular chondrocytes,” Experimental Cell Research, vol. 288, no. 1, pp. 208–217, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Scharstuhl, H. L. Glansbeek, H. M. van Beuningen, E. L. Vitters, P. M. van der Kraan, and W. B. van den Berg, “Inhibition of endogenous TGF-β during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair,” The Journal of Immunology, vol. 169, no. 1, pp. 507–514, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Zhen, C. Wen, X. Jia et al., “Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis,” Nature Medicine, vol. 19, no. 6, pp. 704–712, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Andersen, C. Black, P. Crepeau et al., “TGF-β1 and HtrA1 interactive pathway in the molecular progression of osteoarthritis (1139.9),” The FASEB Journal, vol. 28, no. 1, supplement, article 1139.9, 2014. View at Google Scholar
  60. S. Launay, E. Maubert, N. Lebeurrier et al., “HtrA1-dependent proteolysis of TGF-β controls both neuronal maturation and developmental survival,” Cell Death and Differentiation, vol. 15, no. 9, pp. 1408–1416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Siebert, S. K. Wilhelm, J. Z. Kartchner et al., “Effect of pharmacological blocking of TLR-4 on osteoarthritis in mice,” Journal of Arthritis, vol. 4, article 164, 2015. View at Publisher · View at Google Scholar
  62. D. W. Macdonald, R. S. Squires, S. A. Avery et al., “Structural variations in articular cartilage matrix are associated with early-onset osteoarthritis in the spondyloepiphyseal dysplasia congenita (sedc) mouse,” International Journal of Molecular Sciences, vol. 14, no. 8, pp. 16515–16531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. H.-J. Yen, M. K. Tayeh, R. F. Mullins, E. M. Stone, V. C. Sheffield, and D. C. Slusarski, “Bardet-Biedl syndrome genes are important in retrograde intracellular trafficking and Kupffer's vesicle cilia function,” Human Molecular Genetics, vol. 15, no. 5, pp. 667–677, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Ahrens, A. E. Koch, R. M. Pope, M. Stein-Picarella, and M. J. Niedbala, “Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis,” Arthritis and Rheumatism, vol. 39, no. 9, pp. 1576–1587, 1996. View at Publisher · View at Google Scholar · View at Scopus
  65. G. Keyszer, I. Lambiri, R. Nagel et al., “Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers,” Journal of Rheumatology, vol. 26, no. 2, pp. 251–258, 1999. View at Google Scholar · View at Scopus
  66. G. Cunnane, O. Fitzgerald, C. Beeton, T. E. Cawston, and B. Bresnihan, “Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis,” Arthritis & Rheumatism, vol. 44, no. 10, pp. 2263–2274, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Sathyamoorthy, G. Sandhu, L. B. Tezera et al., “Gender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis,” PLoS ONE, vol. 10, no. 1, article e0117605, 2015. View at Publisher · View at Google Scholar
  68. J. Collazos, V. Asensi, G. Martin, A. H. Montes, T. Suárez-Zarracina, and E. Valle-Garay, “The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions,” Clinical and Experimental Immunology, vol. 182, no. 2, pp. 213–219, 2015. View at Publisher · View at Google Scholar · View at Scopus